Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents

This study has been completed.
Sponsor:
Collaborators:
Aarhus University Hospital
Aage Bangs Fond
AbbVie
Region Midt Forskningsfond
Information provided by (Responsible Party):
University of Aarhus
ClinicalTrials.gov Identifier:
NCT01356758
First received: May 9, 2011
Last updated: December 18, 2015
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):